CDK5 and cancer: CDK5 was discovered in the early 1990 as proline-directed serine/threonine kinase in the CNS and emerged as a crucial regulator of neuronal development, function and disease.5 Recently, CDK5 has been proposed to possess other functions than that in nervous system, especially in cancer progression.